Project description
A point-of-care assessment of glycosylated hemoglobin
Long-term management of diabetes relies on the assessment of glycated hemoglobin, also known as glycosylated hemoglobin (HbA1c). However, this test requires specialised laboratory equipment and in individuals with hemoglobin variants it fails to accurately estimate the HbA1c fraction. To address this need, the EIC-funded VortexLC project aims to develop a novel device capable of providing an improved HbA1c analysis at the point of care. Researchers will undertake technological advances to miniaturise the assay and enable the quantification of HbA1c variants in an easy and cost-effective manner suitable for the millions of diabetes patients worldwide.
Fields of science
- medical and health sciencesclinical medicineendocrinologydiabetes
- natural scienceschemical sciencespolymer sciences
- engineering and technologymaterials engineeringcoating and films
- medical and health sciencesbasic medicineneurologystroke
- engineering and technologymedical engineeringmedical laboratory technologylaboratory samples analysis
Programme(s)
Funding Scheme
HORIZON-AG - HORIZON Action Grant Budget-BasedCoordinator
1050 Brussel
Belgium
See on map
Participants (3)
15341 Agia Paraskevi
See on map
8010 Graz
See on map
13710 Fuveau
See on map